Kosel Medical's 14F Large-Bore Peripheral Thrombus Aspiration Catheter Receives NMPA Approval
Kossel
Vascular Interventional Device Manufacturer and R&D Developer
Recently, Kossel Medtech (Suzhou) Co., Ltd., a company within Medpark, independently developedPeripheral Thrombus Aspiration Catheter (China Medical Device Registration No. 20253031757), approved for marketing by the National Medical Products Administration (NMPA).
This product will be used in conjunction with the previously approved medical electric suction apparatus (JS Medical Device Registration No. 20252141564), disposable suction connecting tube (JS Medical Device Registration No. 20252141452), negative pressure suction collection device (JS Medical Device Filing No. 20252109), and the separator currently under certification, collectively forming Kossel."K-Rhino RhinoPeripheral Thrombus Aspiration System，For the aspiration of thrombi in peripheral arteries and veins。
It is understood that the treatment of peripheral vascular thrombotic diseases includes systemic thrombolysis, venotomy and thrombectomy, catheter-directed thrombolysis (CDT), and percutaneous mechanical thrombectomy (PMT). In recent years, PMT has been increasingly applied in clinical practice. However, during the thrombus aspiration process, clinicians face many challenges such as incomplete aspiration, excessive residue, catheter blockage, and significant blood loss.
In response to the aforementioned clinical pain points, Kossel has successfully developed14F Large-Bore Aspiration CatheterAnd launched into the market. This product can significantly improve suction efficiency, shorten operation time, and has remarkable clinical efficacy.
Production
Product
Excellent
Momentum
14FExtra-large caliber, powerful suction
Thrombus Separation Technology, Aspiration "Smooth and Unobstructed"
Four-layer structure of the tube body, durable against folding, not easy to deform
Non-invasive curved-tip circumferential aspiration leaves thrombus "nowhere to hide"
The launch of the "K-Rhino Rhino" Peripheral Thrombus Aspiration System will further enrich Kossel's product portfolio in the field of peripheral vascular intervention, providing clinical solutions for efficient and minimally invasive removal of peripheral vascular thrombi. This product helps enhance the treatment capability and surgical efficiency for complex thrombus cases, optimize clinical operation processes, and benefit more patients.
Kossel Medtech (Suzhou) Co., Ltd
Kossel was established in November 2013 and is located in the Longshan Science Park, Phase 1 of the Jiangsu Medical Device Technology Park Medpark. It has now become a platform enterprise in the field of泛血管介入器械, forming a "one core, three wings" business layout. Kossel is committed to building a "one-stop" treatment system for peripheral interventions. Its subsidiary, Haiyu Xincheng, focuses on the cardiac electrophysiology field, while its subsidiary, Mixin Medical, concentrates on the research and development of coronary intervention products and the transfer of overseas technologies. Additionally, its subsidiary, Haiwang Medical, is dedicated to overcoming the "bottleneck" technology of medical core raw materials.
